Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway

OBJECTIVE: This study aims to investigate the using of bone marrow mesenchymal stem cells (BMSCs) genetically engineered to produce interferon-β (IFN-β) as a gene delivery system to treat hepatocellular carcinoma (HCC) in vitro and in vivo. METHODS: To measure the effects on tumour cell growth in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, C, Xie, D-Y, Lin, B-L, Zhang, G-L, Wang, P-P, Peng, L, Gao, Z-L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778282/
https://www.ncbi.nlm.nih.gov/pubmed/23887606
http://dx.doi.org/10.1038/bjc.2013.422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778282/
https://www.ncbi.nlm.nih.gov/pubmed/23887606
http://dx.doi.org/10.1038/bjc.2013.422

Ejemplares similares